PFGAX
Price
$13.30
Change
+$0.08 (+0.61%)
Updated
Aug 24 closing price
Net Assets
750.26M
WHOSX
Price
$9.94
Change
-$0.00 (-0.00%)
Updated
Aug 24 closing price
Net Assets
105.71M
Interact to see
Advertisement

PFGAX vs WHOSX

PFGAX vs WHOSX Comparison Chart in %
View a ticker or compare two or three
VS
PFGAX vs. WHOSX commentary
Aug 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PFGAX is a Hold and WHOSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PFGAX has more cash in the bank: 750M vs. WHOSX (106M). PFGAX (4.07) and WHOSX (3.97) have matching dividends . PFGAX was incepted earlier than WHOSX: PFGAX (30 years) vs WHOSX (40 years). PFGAX (4.00) is less costly to investors than WHOSX (0.73). PFGAX is a more actively managed with annual turnover of: 142.00 vs. WHOSX (4.00). PFGAX has a lower initial minimum investment than WHOSX: PFGAX (1000) vs WHOSX (2000). WHOSX annual gain was more profitable for investors over the last year : 2.00 vs. PFGAX (-0.66). PFGAX return over 5 years is better than : -32.90 vs. WHOSX (-38.21).
PFGAXWHOSXPFGAX / WHOSX
Total Expense Ratio4.000.73549%
Annual Report Gross Expense Ratio4.000.73549%
Fund Existence30 years40 years-
Gain YTD-3.378-0.484698%
Front Load4%N/A-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets750M106M708%
Annual Yield % from dividends4.073.97103%
Returns for 1 year-0.662.00-33%
Returns for 3 years1.80-4.04-44%
Returns for 5 years-32.90-38.2186%
Returns for 10 years-37.09-36.96100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDEYX22.080.04
+0.18%
Columbia Intrinsic Value Institutional 3
VESIX49.41N/A
N/A
Vanguard European Stock Instl
ADCVX22.63N/A
N/A
American Century Disciplined Growth A
TSLIX6.77N/A
N/A
Transamerica Small Cap Value I
DSEFX42.17-0.14
-0.33%
Domini Impact Equity Investor